
New Alliance Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
New Alliance Capital specializes in early, growth stage and pre-IPO investments.
Investor Profile
New Alliance Capital has made 20 investments, with 4 in the past 12 months and 10% as lead.
Stage Focus
- Series B (30%)
- Series D (25%)
- Series A (20%)
- Series C (10%)
- Seed (10%)
- Series Unknown (5%)
Country Focus
- China (70%)
- Israel (15%)
- United States (15%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Biopharma
- Artificial Intelligence (Ai)
- Machine Learning
- Manufacturing
- Software
- Pharmaceutical
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.